Introduction
iCAN is a groundbreaking Finnish Research Flagship dedicated to solving the cancer challenge through cutting-edge discovery and innovation. The flagship is at the interface of precision cancer medicine and digital health, with the aim of advancing research and providing innovative solutions to tackle cancer.
iCAN News and Events
Mission Possible – Delivering translational impact
More than 360 participants: speakers, researchers, clinicians, patients, sponsors, and other cancer research specialists gathered in Little Finlandia (Helsinki) on…
Professor Satu Mustjoki awarded the 2025 iCMLf Rowley Prize
The International Chronic Myeloid Leukemia Foundation (iCMLf) has announced that Professor Satu Mustjoki, Scientific Director of the iCAN – Digital Precision…
New funding from Jane and Aatos Erkko Foundation accelerates cancer innovation
The Jane and Aatos Erkko Foundation has announced its latest round of research funding – a highly competitive call where…
iCAN in Numbers
iCAN Study Participants
Company collaborations
iCAN Publications
Invention
Disclosures
Patents
External Funding
